What You Should Know:
- PhaseV, a company at the forefront of applying artificial intelligence (AI) and machine learning (ML) to clinical development raies $50M in Series A funding round co-led by Accel and Insight Partners, with participation from existing investors Viola Ventures, EXOR, and LionBird. This round brings PhaseV's total funding to date to $65M.
- The new capital is earmarked to fuel PhaseV’s mission to support pharmaceutical companies, biotech firms, and contract
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
QuantHealth Unveils Its Large Real-World Drug Model in AWS Marketplace
What You Should Know:
QuantHealth has launched LRDM v1.0, the world’s first clinical trial foundation model that simulates patient outcomes using data from over 100 million individuals and billions of clinical datapoints.This technology marks a pivotal shift by applying large-scale AI modeling to clinical trial design—where 90% of drug candidates fail—offering the potential to cut waste, reduce timelines, and improve success rates
QuantHealth Unveils First-Ever Clinical Trial
Read More
SHINE Technologies to Acquire Lantheus’ SPECT Imaging Business
What You Should Know:
- SHINE Technologies, a nuclear fusion company with an expanding platform of medical isotope products, today announced it has entered into a definitive agreement to acquire the SPECT (Single-Photon Emission Computed Tomography) business from Lantheus, a leading radiopharmaceutical-focused company.
- The strategic acquisition includes the portion of Lantheus' North Billerica, Massachusetts campus dedicated to the manufacturing of its SPECT products.
SHINE's
Read More
Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton
What You Should Know:
- Robotics startup Wandercraft has begun clinical trials for its new Personal Exoskeleton.
- Founded by Nicolas Simon, whose siblings face mobility challenges from Charcot-Marie-Tooth disease, Wandercraft aims to help individuals with spinal cord injuries, stroke, and other severe neuromuscular disorders stand and walk again using advanced robotics and artificial intelligence.
From Rehabilitation Tool to Personal Mobility
Wandercraft is already known
Read More
Verily Receives $14.7M Grant from Michael J. Fox Foundation to Create Rich Molecular Dataset for Parkinson’s Research
What You Should Know:
- Verily, an Alphabet company focused on health data platforms and AI, today announced it has received a significant $14.7M grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF).
- The funding will support the generation of a comprehensive molecular dataset aimed at accelerating research into Parkinson’s disease.
Building on the Personalized Parkinson’s Project
The new initiative will leverage and significantly expand upon data
Read More
Basil Systems Secures $11.5M to Expand AI-Powered Intelligence Platform for Life Sciences
What You Should Know:
- Basil Systems, a provider of an AI-powered product lifecycle intelligence platform tailored for the life sciences industry, announced it has raised a total of $11.5M in funding led by Golden Ventures, with participation from Hearst Ventures and Argosy Capital.
- The infusion of capital is earmarked for significant expansion efforts, including enhancing its enterprise BasilIntel SaaS platform, deepening product capabilities, and accelerating the adoption of
Read More
Immunai & Parker Institute to Build Largest Single-Cell Immune Profiling Patient Database
What You Should Know:
- Immunai, a leading AI biotech company specializing in mapping the human immune system and the Parker Institute for Cancer Immunotherapy (PICI), a collaborative consortium of the world’s leading immuno-oncology experts, announced today that they will build the world’s largest single-cell dataset from patients treated with standard-of-care (SoC) immunotherapy.
- Under the collaboration with PICI,
Read More
DHL Express Launches Next-Day Brazil-to-USA Medical Express Service for Clinical Trials
What You Should Know:
- DHL Express, the world's leading international express services provider, today announced a significant expansion of its specialized Medical Express (WMX) service, adding a next-day delivery capability for the critical Brazil-to-USA lane.
- The enhancement connects South America and Puerto Rico more efficiently to the United States, providing crucial support for customers in the pharmaceutical and clinical research sectors navigating complex global
Read More
Eli Lilly’s Oral GLP-1 Shows Positive Trial Results for Type 2 Diabetes
What You Should Know:
- Eli Lilly and Company announced positive topline Phase 3 results from ACHIEVE-1, a study evaluating the safety and efficacy of orforglipron compared to placebo in adults with type 2 diabetes whose blood sugar was inadequately controlled through diet and exercise alone.
- Orforglipron stands out as the first oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist, taken without food and water restrictions, to successfully complete a Phase 3
Read More
The AI Hype Cycle in MedTech: Navigating the Trough of Disillusionment
The emerging technologies hype cycle had multiple AI applications at the peak of inflated expectations in 2023 and were just beginning the ride down to the Trough of Disillusionment in 20241 2. For years, it’s been said that “the use of data and algorithms is going to transform healthcare.” While true to a degree, we see that MedTech companies that invest in trends like artificial neural networks, analytics, big data analytics, and now AI, often struggle to yield a significant return on
Read More
